BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28101144)

  • 1. Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation.
    Corallo C; Cutolo M; Volpi N; Franci D; Aglianò M; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Ther Adv Musculoskelet Dis; 2017 Jan; 9(1):3-10. PubMed ID: 28101144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological features of systemic sclerosis-associated myopathy: A scoping review.
    Lefebvre F; Giannini M; Ellezam B; Leclair V; Troyanov Y; Hoa S; Bourré-Tessier J; Satoh M; Fritzler MJ; Senécal JL; Hudson M; Meyer A; Landon-Cardinal O
    Autoimmun Rev; 2021 Jul; 20(7):102851. PubMed ID: 33971337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis-associated myopathy.
    Ranque B; Authier FJ; Berezne A; Guillevin L; Mouthon L
    Ann N Y Acad Sci; 2007 Jun; 1108():268-82. PubMed ID: 17899625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
    Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
    Honda M; Shimizu F; Sato R; Nakamori M
    J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic VEGF isoform in inflammatory myopathies.
    Volpi N; Pecorelli A; Lorenzoni P; Di Lazzaro F; Belmonte G; Aglianò M; Cantarini L; Giannini F; Grasso G; Valacchi G
    Mediators Inflamm; 2013; 2013():219313. PubMed ID: 23840094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality.
    Paik JJ; Wigley FM; Shah AA; Corse AM; Casciola-Rosen L; Hummers LK; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1764-1770. PubMed ID: 28544788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First pilot study of extracellular volume MRI measurement in peripheral muscle of systemic sclerosis patients suggests diffuse fibrosis.
    Dumitru RB; Goodall AF; Broadbent DA; Del Galdo F; Tan AL; Biglands JD; Buch MH
    Rheumatology (Oxford); 2022 Apr; 61(4):1651-1657. PubMed ID: 34273164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
    Suárez-Calvet X; Alonso-Pérez J; Castellví I; Carrasco-Rozas A; Fernández-Simón E; Zamora C; Martínez-Martínez L; Alonso-Jiménez A; Rojas-García R; Turón J; Querol L; de Luna N; Milena-Millan A; Corominas H; Castillo D; Cortés-Vicente E; Illa I; Gallardo E; Díaz-Manera J
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32144182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus.
    Pauling JD; Skeoch S; Paik JJ
    Indian J Rheumatol; 2020 Dec; 15(6):81-90. PubMed ID: 33790525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
    Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
    Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A descriptive and prognostic study of systemic sclerosis-associated myopathies.
    Ranque B; Authier FJ; Le-Guern V; Pagnoux C; Berezne A; Allanore Y; Launay D; Hachulla E; Kahan A; Cabane J; Gherardi R; Guillevin L; Mouthon L
    Ann Rheum Dis; 2009 Sep; 68(9):1474-7. PubMed ID: 19054827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort.
    Matas-García A; Guillén-Del-Castillo A; Kisluk B; Selva-O'Callaghan A; Espinosa G; Prieto-González S; Moreno Lozano P; Garrabou G; Grau-Junyent JM; Simeon-Aznar CP; Milisenda JC
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI82-SI90. PubMed ID: 35713496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis.
    Ross L; Lindqvist A; Costello B; Hansen D; Brown Z; Day JA; Stevens W; Burns A; Perera W; Pianta M; La Gerche A; Nikpour M
    Arthritis Res Ther; 2022 Apr; 24(1):84. PubMed ID: 35410246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ.
    Ghannam K; Martinez-Gamboa L; Spengler L; Krause S; Smiljanovic B; Bonin M; Bhattarai S; Grützkau A; Burmester GR; Häupl T; Feist E
    PLoS One; 2014; 9(8):e104048. PubMed ID: 25098831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
    Miller T; Al-Lozi MT; Lopate G; Pestronk A
    J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):420-8. PubMed ID: 12235311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis.
    Flower VA; Barratt SL; Ward S; Pauling JD
    Curr Rheumatol Rev; 2019; 15(2):99-109. PubMed ID: 30091416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis-Induced Thrombotic Microangiopathies.
    Gouin A; Ribes D; Colombat M; Chauveau D; Prevot G; Lairez O; Pugnet G; Fremeaux-Bacchi V; Huart A; Belliere J; Faguer S
    Kidney Int Rep; 2021 Apr; 6(4):1015-1021. PubMed ID: 33912751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.